Compare Adaptive Biotechnologies Corp (ADPT) vs C.H. Robinson Worldwide, Inc. (CHRW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs C.H. Robinson Worldwide, Inc. — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while C.H. Robinson Worldwide, Inc. trades at $145.4 (market cap $16.96B). The key difference: C.H. Robinson Worldwide, Inc. is far larger — about 4.2× Adaptive Biotechnologies Corp's market cap, and C.H. Robinson Worldwide, Inc. pays a 1.74% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | CHRW | |
|---|---|---|
Market Cap | $4.04B | $16.96B |
Sector | Health | Industrials |
52-Week High | $25.45 | $209.42 |
52-Week Low | $12.30 | $118.77 |
Enterprise Value | $4.10B | $18.78B |
Dividend Yield | — | 1.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About C.H. Robinson Worldwide, Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (57% of 2021 net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm also operates a large air and ocean forwarding division (34%), which has grown organically and via tuck-in acquisitions. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.
Read more on CHRW →
